Zhejiang Conba Pharmaceutical (600572.SH): Zhejiang Conba Pharmaceutical Group plans to reduce its shareholding by no more than 1%.
Zhejiang Conba Pharmaceutical (600572.SH) announced that its second-largest shareholder, Zhejiang Conba Pharmaceutical Group, due to funding needs for developing its own business, plans to reduce its shareholding in the company through centralized bidding on the Shanghai Stock Exchange within 3 months starting 15 trading days after the disclosure date of the announcement. The number of shares to be reduced shall not exceed 25.403 million shares, and the proposed reduction ratio shall not exceed 1% of the company's total share capital.
Zhejiang Conba Pharmaceutical (600572.SH) announced that its second-largest shareholder, Zhejiang Conba Pharmaceutical Group, due to funding needs for developing its own business, plans to reduce its shareholding in the company through centralized bidding on the Shanghai Stock Exchange within 3 months after 15 trading days from the date of this announcement disclosure. The number of shares to be reduced shall not exceed 25.403 million shares, and the reduction ratio shall not exceed 1% of the company's total share capital.
Related Articles
.png)
HBM HOLDINGS-B (02142) repurchased 700,000 shares for HK$7.1914 million on October 14.
XINXIN MINING (03833) re-elects Chen Yin as Chairman of the Board.
YEAHKA (09923) repurchased 39,200 shares for HK$146,200 on October 14.
HBM HOLDINGS-B (02142) repurchased 700,000 shares for HK$7.1914 million on October 14.
XINXIN MINING (03833) re-elects Chen Yin as Chairman of the Board.
YEAHKA (09923) repurchased 39,200 shares for HK$146,200 on October 14.
